Skip to main content

$114M Settlement For Rhode Island Over Opioid Crisis

$114M Settlement For Rhode Island Over Opioid Crisis

$114M Settlement For Rhode Island Over Opioid Crisis

Introduction

A settlement of more than $114 million has been reached between Rhode Island and opioid manufacturer and distributors over the opioid crisis in the state.

State Attorney General Peter Neronha announced that opioid manufacturer, Johnson & Johnson (J&J) will pay $21.1 million and opioid distributors, AmerisourceBergen, Cardinal Health and McKesson will pay  $90.8 million of the settlement amount. The settlement amount will be used to fight the opioid crisis and help opioid-addicted people.

The AG even stated that all these companies prioritized profits by overseeing the drawbacks of addictive opioids. The current settlement is separate from the nationwide $26 billion opioid settlement where most of the U.S. states have joined for a coordinated result.

Rhode Island will get the settlement amount within the next few weeks, and the second payment is expected in July. It also ensures that the state will get the money irrelevant to the final approval of the global opioid settlement.

The state will put an advisory board to decide how to use 80% of the settlement amount as 20% will be directly distributed to cities and towns to fight the opioid crisis.

The U.S. has witnessed hundreds of thousands of opioid overdose deaths and the drug distributors, along with J&J, face more than 3,300 lawsuits in federal courts across the nation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!